Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Published: Oct-2017

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia – high blood glucose levels.....

$4995
More Info
Frontier Pharma:Cancer Immunotherapies – First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets

Published: Sep-2017

Cancer is a group of diseases that are defined by abnormal cell growth, local tissue invasion and eventual migration to.....

$6995
More Info
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

Published: Sep-2017

This report provides insight into the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified.....

$4995
More Info
Global Respiratory Drugs Market to 2023 – A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

Published: Sep-2017

The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as inflammation,.....

$4995
More Info
$6995
More Info
Frontier Pharma: Cardiovascular Disease – Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

Published: Aug-2017

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart.....

$6995
More Info
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 – Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape

Published: Aug-2017

Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV), which can lead to acute and chronic.....

$4995
More Info
Global Ophthalmology Drugs Market to 2023- Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape

Published: Aug-2017

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system,.....

$4995
More Info
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017

Published: Aug-2017

This report provides an overview of the pipeline landscape for genetic ophthalmological disorders. The report provides.....

$3995
More Info
Hepatitis Drug Development Pipeline Review, 2017

Published: Aug-2017

This report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on.....

$3995
More Info
Sort by: